|
|
Volumn 22, Issue 1, 2004, Pages 15-18
|
|
Signal transduction inhibitors - A work in progress
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AE 941;
BEVACIZUMAB;
CEP 1347;
CEP 701;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;
ERLOTINIB;
GEFITINIB;
IMATINIB;
ISIS 3521;
NIMOTUZUMAB;
PANITUMUMAB;
PROTEIN KINASE INHIBITOR;
R11577;
RAPAMYCIN;
RITUXIMAB;
RUBOXISTAURIN;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VATALANIB;
VEGF TRAP;
CHRONIC MYELOID LEUKEMIA;
COLORECTAL CANCER;
DRUG INDICATION;
DRUG MECHANISM;
DRUG SAFETY;
HUMAN;
INTERSTITIAL PNEUMONIA;
LUNG CANCER;
PRIORITY JOURNAL;
REVIEW;
SIGNAL TRANSDUCTION;
ENZYME INHIBITORS;
HUMANS;
MODELS, BIOLOGICAL;
MODELS, CHEMICAL;
MODELS, MOLECULAR;
NEOPLASMS;
SIGNAL TRANSDUCTION;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0347356355
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0104-15 Document Type: Review |
|
Times cited : (38)
|
|
References (0)
|